Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls.

Sci Rep · 2022 · PMC9246852 · PMID 35773270

Europe PMC DOI

hedged sentence

0.0700

closest p · 1.4× alpha

0.0700

boldest claim

The sentences

a trend toward significancep = 0.07so close (0.05 < p ≤ 0.1)

Supplementary analyses of Psilocybin + HE vs psilocybin + HE + B3 * Time revealed a trend toward significance (F (1, 427) = 3.26, b = − 0.56 , p = 0.07), and the three-way Psilocybin + HE vs psilocybin + HE + B3 * Time * Age interaction was identified (F (1, 427) = 6.71, b = 0.66 , p = 0 . 01), indicating that effects were more pronounced among older respondents.

also in 3,729 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.